Hong Shi

The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4

Li Liu, Patrick A. Mayes, Stephen D. Eastman et al. · Clinical Cancer Research · 2015 · 447 citations

Medicine, Immunology, Oncology +17

Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments

Jong W. Yu, Sabyasachi Bhattacharya, Niranjan Yanamandra et al. · PLoS ONE · 2018 · 205 citations · Full text

Medicine, Immunology, Oncology +17

Leptin induces functional activation of cyclooxygenase‐2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells

Jingchun Gao, Jianxin Tian, Yunyi Lv et al. · Cancer Science · 2008 · 193 citations · Full text

Life Sciences, Molecular Biology, Oncology +15

Belantamab Mafodotin (GSK2857916) Drives Immunogenic Cell Death and Immune-mediated Antitumor Responses<i>In Vivo</i>

Rocío Montes de, Alireza Alavi, Nick Vitali et al. · Molecular Cancer Therapeutics · 2021 · 111 citations · Full text

Life Sciences, Immunology, Oncology +17

Expression and Localization of Luteinizing Hormone Receptor in the Female Mouse Reproductive Tract1

Meilin Zheng, Hong Shi, Deborah L. Segaloff et al. · Biology of Reproduction · 2001 · 94 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +13